Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential

Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

Should You Invest $1,000 in Denali Therapeutics Right Now?

Before you consider Denali Therapeutics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Denali Therapeutics wasn't on the list.

While Denali Therapeutics currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Companies Mentioned in This Article

Company	MarketRank™	Current Price	Price Change	Dividend Yield	P/E Ratio	Consensus Rating	Consensus Price Target
Denali Therapeutics (DNLI)	3.388 of 5 stars	$24.92	-0.1%	N/A	N/A	Moderate Buy	$35.92
Ultragenyx Pharmaceutical (RARE)	3.4463 of 5 stars	$25.83	2.0%	N/A	N/A	Moderate Buy	$58.89
Sarepta Therapeutics (SRPT)	3.7092 of 5 stars	$18.79	-2.2%	N/A	N/A	Hold	$25.06
Pfizer (PFE)	3.3704 of 5 stars	$28.00	0.8%	6.14%	36.84	Hold	$28.28
Exelixis (EXEL)	3.3853 of 5 stars	$54.08	0.7%	N/A	17.01	Hold	$50.07
Moderna (MRNA)	1.6511 of 5 stars	$145.07	8.8%	N/A	N/A	Hold	$69.50
United Therapeutics (UTHR)	4.2033 of 5 stars	$513.12	-1.5%	N/A	18.36	Moderate Buy	$646.00
Biogen (BIIB)	3.9582 of 5 stars	$216.78	1.1%	N/A	38.37	Moderate Buy	$227.07
Sanofi (SNY)	2.8003 of 5 stars	$45.85	1.6%	3.84%	24.01	Hold	$49.50
Eli Lilly and Company (LLY)	4.7946 of 5 stars	$1,257.26	1.0%	0.55%	42.19	Moderate Buy	$1,292.18

Compare These Stocks Add These Stocks to My Watchlist

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential

Upgrade Now

Should You Invest $1,000 in Denali Therapeutics Right Now?

Companies Mentioned in This Article

Featured Articles and Offers

Recent Videos

Stock Lists

Investing Tools

Search Headlines

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential

Upgrade Now

Should You Invest $1,000 in Denali Therapeutics Right Now?

Companies Mentioned in This Article

Featured Articles and Offers

Recent Videos

Stock Lists

Investing Tools

Search Headlines

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools